The Next Generation in Bilevel Therapy Now Available on ResMed's Award-Winning S9(TM) Platform

The S9 Platform Combined With ResMed's Proven Bilevel Therapy is a Revolutionary Step in Bringing Patient Comfort and Compliance Together Into One Intuitive and Easy-to-use System

OSLO, Norway, April 11, 2011 - ResMed (NYSE:RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment, announced the launch of its next
generation bilevel therapy devices.

"We are proud to announce the launch of the bilevel range of products on
the S9(TM) platform, our latest and most innovative flow generator system for
treating respiratory disorders including sleep-disordered breathing (SDB).
Now, for the first time in our history, patients have one platform that can
treat obstructive sleep apnea, central sleep apnea and Cheyne-Stokes
respiration as well as provide noninvasive ventilation (NIV) for patients
requiring ventilatory support," said Michael Farrell, SVP of the Global Sleep
Business Unit at ResMed. "Our goal is to increase patients' quality of life
by providing comfortable, quiet, easy-to-use, and highly effective treatment.
A critical element of successful treatment is long-term adherence to therapy.
Since its launch just over a year ago, the S9 Series has been able to help
physicians and respiratory therapists achieve that goal - driving therapeutic
compliance by patients around the globe."

Historically, patients' ability to comply with sleep or respiratory
therapies was negatively affected by noisy devices, nasal dryness/congestion
and breathing discomfort. To combat these negative effects and increase
patients' ability to adhere to respiratory therapy, ResMed's next generation
bilevel devices build on features that are crucial to maintaining and
increasing overall patient compliance.

ResMed's enhanced Easy-Breathe(TM) motor technology reduces noise
transferred through the mask to the patient by 78%, compared to the S8(TM)
Series II. The improved ClimateControl(TM) system ensures consistent
therapeutic air temperature and humidification, working to prevent rain-out
and dryness, independent of external ambient conditions. With the integration
of ResMed's Vsync(TM), TiControl(TM), and Easy-Breath waveform technologies,
each device can now be fine-tuned to synchronise to the specific needs of
each individual patient. Finally, patient data can now be accessed via the
easy-to-use color screen or can be downloaded in high resolution and viewed
in ResMed's ResScan(TM) software.

"We remain focused on providing best in class NIV solutions; now
delivering NIV therapy by way of a smaller, lighter, and quieter platform.
The VPAP ST offers unmatched therapy performance to a broader range of
patients through the enhancements of our clinically proven synchronisation
algorithms, Vsync and TiControl alongside Climate Control and a higher backup
rate," said Geoff Neilson, Vice President - Ventilation Strategic Business
Unit.

ResMed's new pressure support bilevel devices include the VPAP(TM) S, a
bilevel pressure support therapy device; the Auto 25, an auto-adjusting
bilevel therapy device; the AutoSet CS(TM), the adaptive servo-ventilation
therapy device; and the VPAP(TM) ST, a noninvasive pressure support
ventilator. All four devices are built to meet the highest standard of
effective therapy, comfortable treatment, and ease of use.

For additional product information visit www.resmed.com

About ResMed

ResMed is a leading developer, manufacturer, and distributor of medical
equipment for treating, diagnosing, and managing sleep-disordered breathing
and other respiratory disorders. We are dedicated to developing innovative
products to improve the lives of those who suffer from these conditions and
to increasing awareness among patients and healthcare professionals of the
potentially serious health consequences of untreated sleep-disordered
breathing. For more information on ResMed, visit www.resmed.com

    Contact ResMed:

    Henrik Aase
    Marketing Communications Director - Europe
    Office: +47-67-11-88-59 | Mobile: +47-97-53-91-12
    henrik.aase@resmed.com

    For interviews, photos, additional info:

    Rikke Eckhoff, Burson-Marsteller Oslo
    Mobile : +47-990-82-202
    rikke.eckhoff@bm.com

Contact ResMed: Henrik Aase, Marketing Communications Director - Europe, Office: +47-67-11-88-59 | Mobile: +47-97-53-91-12, henrik.aase at resmed.com; For interviews, photos, additional info: Rikke Eckhoff, Burson-Marsteller Oslo, Mobile : +47-990-82-202, rikke.eckhoff at bm.com